Journal of neuroimaging : official journal of the American Society of Neuroimaging
-
Randomized Controlled Trial Multicenter Study Clinical Trial
SonoVue in transcranial Doppler investigations of the cerebral arteries.
The authors investigated the safety and diagnostic potential of a new ultrasound contrast agent (SonoVue) using transcranial color-coded duplex sonography (TCCS). ⋯ The results obtained from this multicenter study demonstrate that the administration of SonoVue to patients with ischemic cerebrovascular disease who undergo TCCS examination of cerebral vessels improves the visualization of intracranial arteries, providing a dose-dependent contrast enhancement and a clinically useful duration of signal enhancement related to the dose. During this multicenter study, SonoVue proved to be a safe and well-tolerated compound.